{"id":105211,"date":"2020-04-12T07:05:11","date_gmt":"2020-04-12T14:05:11","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2020\/04\/gold-may-soon-soar-to-a-record-2000-says-analyst-we-borrowed-from-the-future-and-there-is-not-enough-economy-to-pay-it-down"},"modified":"2020-04-12T07:05:11","modified_gmt":"2020-04-12T14:05:11","slug":"gold-may-soon-soar-to-a-record-2000-says-analyst-we-borrowed-from-the-future-and-there-is-not-enough-economy-to-pay-it-down","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2020\/04\/gold-may-soon-soar-to-a-record-2000-says-analyst-we-borrowed-from-the-future-and-there-is-not-enough-economy-to-pay-it-down","title":{"rendered":"Gold may soon soar to a record $2,000 says analyst: we \u2018borrowed from the future, and there is not enough economy to pay it down\u2019"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/gold-may-soon-soar-to-a-record-2000-says-analyst-we-borrowed-from-the-future-and-there-is-not-enough-economy-to-pay-it-down3.jpg\"><\/a><\/p>\n<p>The precious metal has been torn between its potential as a haven investment and a mad scramble to sell the tangible asset in a bid for cash to cover losses in the stock market.<\/p>\n<p>\u201cThe Covid-19 outbreak has had a major impact on the gold market, bringing massive price swings as investors react to new developments related to the pandemic,\u201d says Steven Dunn, head of exchange-traded funds at Aberdeen Standard Investments.<\/p>\n<p>\u201cBecause of Covid-19, refiners were knocked offline\u2026and the ability to move gold became a challenge as normal means of transport became almost impossible,\u201d he says.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The precious metal has been torn between its potential as a haven investment and a mad scramble to sell the tangible asset in a bid for cash to cover losses in the stock market. \u201cThe Covid-19 outbreak has had a major impact on the gold market, bringing massive price swings as investors react to new [\u2026]<\/p>\n","protected":false},"author":513,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,39,45],"tags":[],"class_list":["post-105211","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-economics","category-finance"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/105211","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/513"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=105211"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/105211\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=105211"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=105211"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=105211"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}